The never-ending trial-and-error process for developing effective treatments for diseases like malaria, HIV, and tuberculosis is one of the largest difficulties faced by organizations and businesses around the world. Government agencies and pharmaceutical firms are working extremely hard to set up plans for the creation of treatments for these diseases. Additionally, it is projected that during the forecast period, the prevalence of infectious and endemic diseases will rise. The Global vaccines market is predicted to increase at a CAGR of 10.8% from 2021 to 2030.
Market Size and Key Findings
The Global Vaccines Market size is at around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.
Global Vaccines Market Size (In USD Bn)
(2021-2030F)
Market Dynamics
Market Growth Drivers Analysis
The possibility of newly emerging infectious diseases spreading quickly and causing pandemics over the world is a serious issue since people are interacting with wild animals more regularly, traveling much more frequently, and over much greater distances than they did in the past. Additionally, there is a chance that illnesses could spread as a result of the intentional introduction into populations of humans, animals, or plants for harmful objectives.
Market Restraints
The process of developing vaccines requires a significant amount of capital. The cost of storing and shipping vaccinations is higher than that of any other pharmaceutical product because they need specific facilities and monitoring systems. The effectiveness and quality of vaccines can suffer from inadequate storage and delivery infrastructure. The development process takes 10 to 15 years and costs between USD 800 million - USD 1 billion. Additionally, because vaccine development has a low success rate, businesses struggle to control operational expenses and secure initial investments. Therefore, the high cost of vaccine production and storage is limiting market expansion.
Competitive Landscape
Key Players
The prominent players operating in this market include GlaxoSmithKline Plc (UK), Merck & Co., Inc. (US), Sanofi SA (France), Pfizer, Inc. (US), Johnson & Johnson (US), CSL Limited (Australia), Novavax, Inc. (US), Panacea Biotec (India), Sinovac Biotech Ltd. (China) and Mitsubishi Tanabe Pharma Corporation (Japan)
TABLE OF CONTENT
1. Report Description of the Global Vaccines Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Global Vaccines Market Executive Summary
2.1 Global Vaccines Market – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Global Vaccines Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Global Vaccines Market Segmentation
4.1 By Technology
4.1.1 Conjugate Vaccines
4.1.2 Inactivated & Subunit Vaccines
4.1.3 Live-Attenuated Vaccines
4.1.4 Toxoid Vaccines
4.1.5 Viral Vector Vaccines
4.2 By Type
4.2.1 Monovalent Vaccines
4.2.2 Multivalent Vaccines
4.3 By Disease Indication
4.3.1 Pneumococcal Disease
4.3.2 Influenza
4.3.3 Combination Vaccines
4.3.4 HPV
4.3.5 Meningococcal Disease
4.3.6 Herpes Zoster
4.3.7 Rotavirus
4.3.8 MMR
4.3.9 Varicella
4.3.10 Hepatitis
4.3.11 DTP
4.3.12 Polio
4.3.13 COVID-19
4.3.14 Other Disease Indications
4.4 By Route of Administration
4.4.1 Intramuscular and Subcutaneous Administration
4.4.2 Oral Administration
4.4.3 Other Routes Of Administration
4.5 By End User
4.5.1 Pediatric Vaccines
4.5.2 Adult Vaccines
5. Global Vaccines Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Global
8.2 Regulatory Framework in Global
8.3 Pricing & Reimbursement Scenario in Global Vaccines Market
9. Factors Driving Future Growth
9.1 New Trends and Development Global Vaccines Market
9.2 Future Opportunities
10. Strategic Recommendations
Segmentation
Vaccines Market Segmentation
By Technology(excluding COVID-19 vaccines) (Revenue, USD Billion):
Conjugate vaccines
Inactivated & Subunit vaccines
Live Attenuated vaccines
Recombinant vaccines
Toxoid vaccines
Viral vector vaccines
COVID-19 Vaccines Market, by Technology (Revenue, USD Billion):
mRNA vaccines
Viral Vector vaccines
Other vaccines (inactivated, recombinant, conjugate, subunit, peptide, and DNA vaccines)
By Type (Revenue, USD Billion):
Monovalent vaccines
Multivalent vaccines
By Disease Indication (Revenue, USD Billion):
Influenza
Pneumococcal diseases
Combination vaccines
HPV
Herpes Zoster
Meningococcal diseases
Rotavirus
MMR
Varicella
Hepatitis
DTP
Polio
COVID 19
Other disease indications (typhoid, dengue, yellow fever, tuberculosis, cancer, Japanese encephalitis, rabies and allergies)
By Route of Administration (Revenue, USD Billion):
Intramuscular & Subcutaneous administration
Oral administration
Other routes of administration (intranasal, intradermal, and percutaneous)
By End-user
Pediatric vaccines
Adult vaccines
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
